Veterinary cardiologist, Dr. Hayley McDonald Explains All about Felicyn CA-1
Felycin®-CA1 (sirolimus delayed-release tablets) is the first disease-modifying drug that can give hope to owners of cats with subclinical hypertrophic cardiomyopathy (HCM).Felycin®-CA1 is the first and only FDA conditionally approved once-weekly drug for the management of ventricular hypertrophy in cats with subclinical HCM.
When Vaccine Hesitancy Walks Into the Exam Room
In the wake of The New York Times’ recent article, “Vaccine Skepticism Comes for Pet Owners, Too” (Oct. 27, 2025), veterinarians across the country are finding themselves in new — and sometimes uncomfortable — territory.
Cozy Up with the October Issue of Vet Candy Magazine!
From Dubai to Canada to the U.S., veterinarians are transforming what animal care looks like — and feels like. This month, Vet Candy celebrates the innovators redefining the future of our profession through compassion, creativity, and courage.
Cannabidiol (CBD) for Refractory Epilepsy in Dogs: What the Evidence Shows
Cannabidiol (CBD) has gained attention as a potential supplementary treatment for refractory idiopathic epilepsy in dogs. A recent systematic review examined randomized controlled trials (RCTs) evaluating CBD versus placebo in dogs whose seizures were not controlled with standard therapy.
Antimicrobial Resistance in Urinary E. coli of Dogs and Cats: What Vets Should Know
Antimicrobial resistance (AMR) is a growing concern worldwide, affecting humans, animals, and the environment. In dogs and cats, urinary tract infections (UTIs) are common and often caused by antimicrobial-resistant E. coli, making antimicrobial susceptibility testing (AST) essential for effective treatment.
Helping veterinary medicine’s unsung heroes: Finn’s Friends Fund supports CSU technicians
Veterinary technicians are the backbone of animal care—managing complex medical cases, offering emotional support to pets and families, and often navigating financial pressures of their own. To recognize their essential role at the CSU Veterinary Teaching Hospital, three private donors established Finn’s Friends Fund in 2022. The fund honors Finn, a spirited golden retriever who received cancer treatment at the Flint Animal Cancer Center.